Research
Hormonal
Sleep restriction (4 hours/night) impairs glucose tolerance and increases post-breakfast insulin resistance, as measured by elevated HOMA values, despite similar insulin levels to rested conditions.
Sleeping only 4 hours makes your body handle carbohydrates poorly the next morning, leading to higher blood sugar spikes. This happens even if you eat the same amount of food. Prioritize sleep to maintain good glucose tolerance.
GoodSupportsHIGH confidence
Postbreakfast HOMA was significantly elevated (+56%) when the subjects were in a state of sleep debt, compared with fully rested... glucose levels during the first 90 min were higher during sleep restriction than sleep extension, despite insulin levels that were slightly, but not significantly, higher.
Why this rating
Controlled crossover design with oral glucose tolerance testing components.
Source
Leptin Levels Are Dependent on Sleep Duration: Relationships with Sympathovagal Balance, Carbohydrate Regulation, Cortisol, and Thyrotropin
Karine Spiegel et al. · The Journal of Clinical Endocrinology & Metabolism · 2004
DOI 10.1210/jc.2004-1003
crossover · n=11Cited 998×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Restricting sleep duration to 4 hours per night for 6 days significantly decreases circulating leptin levels (mean -19%, maximal -26%) and reduces the amplitude of the diurnal leptin rhythm compared to extended sleep (12 hours).Good
- Sleep restriction (4 hours/night) increases evening cortisol levels and delays the nocturnal nadir, while simultaneously decreasing TSH levels and amplitude, indicating a disruption of the hypothalamo-pituitary-adrenal and thyroid axes.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →